A phase I/II trial of concurrent chemo-radiation with dose-escalated radiotherapy in patients with stage II or stage III non-small cell lung cancer

Geahča maid

• Influence of dose calculation algorithms on isotoxic dose-escalation of non-small cell lung cancer radiotherapy.
  Dahkki: Panettieri, V, et al.
  Almmustuhtton: (2010)
• Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvement.
  Dahkki: Fenwick, J, et al.
  Almmustuhtton: (2009)
• Optimizing collimator margins for isotoxically dose-escalated conformal radiation therapy of non-small cell lung cancer.
  Dahkki: Warren, S, et al.
  Almmustuhtton: (2014)
• Early mucosal reactions during and after head-and-neck radiotherapy: dependence of treatment tolerance on radiation dose and schedule duration.
  Dahkki: Fenwick, J, et al.
  Almmustuhtton: (2008)
• UK proposal for three parallel dose escalation studies in radiotherapy (RT) for Stage I-III non-small cell lung cancer (NSCLQC)-DEAL-RT
  Dahkki: Hughes, S, et al.
  Almmustuhtton: (2007)